Nippon India PHARMA Fund - G

NAV ₹568.601 ↓ -3.24 (-0.57 %) as on 10 Sep 26

📑 Table of contents

Scheme Objective
NAV Price Chart
Returns
- Historical Returns
- Compounded Returns
Growth Of 10k Over Years
Holdings / Portfolio
All Plan & Options
Fund Manager Information
Custodians
Registrar & Transfer Agent (RTA)
Administrator Companies
Auditors

Scheme Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund launched on 5 Jun 04. It is a fund with High risk and has given a CAGR return of 19.9% since its launch. Ranked 35 in Sectoral category. Return for 2025 was -3.3% , 2024 was 34% and 2023 was 39.2% .

Below is the key information for Nippon India Pharma Fund

NAV as on 10 Sep 26	₹568.601 ↓ -3.24 (-0.57 %)
Net Assets (AUM) as on 31 Jul 2026	₹9,279 Cr.
Launch Date	5 Jun 2004
Category	Equity - Sectoral
Rating	☆☆
Type	Open Ended Fund
Risk	High
AMC	Nippon Life Asset Management Ltd.

Alpha Ratio	-4.06
Expense Ratio	1.81 %
Sharpe Ratio	0.179
Information Ratio	-1.14
Benchmark	Not Available
Min Investment	₹5,000
Min SIP Investment	₹100
Exit Load	0-1 Years (1%),1 Years and above(NIL)

NAV Price Chart

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 10 Sep 26

Duration	Returns
1 Month	0.1%
3 Month	6.6%
6 Month	12.3%
1 Year	11.4%
3 Year	18%
5 Year	12.8%
10 Year
15 Year
Since launch	19.9%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.3%
2024	34%
2023	39.2%
2022	-9.9%
2021	23.9%
2020	66.4%
2019	1.7%
2018	3.6%
2017	7.6%

Growth of 10k Over Years

Date	Value

Asset Allocation

Asset Class	Value

Sector Allocation

Sector	Value

Top Securities Holdings / Portfolio

Holdings/Securities

Name	Global Industry	Holding	Value	Quantity

0 of 0

Ready to Invest?
Talk to our investment specialist

All Plan & Options

Fund and Plan	NAV	6 Month	1 Year	3 Year	5 Year
Nippon India Pharma Fund Normal Dividend, Payout	₹122.786 ↓ -0.70	12.3 %	10.77 %	17.16 %	13.29 %
Nippon India Pharma Fund Normal Dividend, Reinvestment	₹122.786 ↓ -0.70	12.3 %	10.77 %	17.16 %	13.29 %
Nippon India Pharma Fund Growth	₹568.601 ↓ -3.24	12.3 %	11.39 %	17.99 %	12.81 %
Data as on 10 Sep 26

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.

Shepard Technologies Pvt. Ltd : 1808, Solus, Hiranandani Estate, Thane, Maharashtra - 400607

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.